Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2015 / Article

Research Article | Open Access

Volume 2015 |Article ID 807158 | https://doi.org/10.1155/2015/807158

H. R. Tufts, C. S. Harris, Z. N. Bukania, T. Johns, "Antioxidant and Anti-Inflammatory Activities of Kenyan Leafy Green Vegetables, Wild Fruits, and Medicinal Plants with Potential Relevance for Kwashiorkor", Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 807158, 9 pages, 2015. https://doi.org/10.1155/2015/807158

Antioxidant and Anti-Inflammatory Activities of Kenyan Leafy Green Vegetables, Wild Fruits, and Medicinal Plants with Potential Relevance for Kwashiorkor

Academic Editor: Marco Leonti
Received28 Apr 2015
Accepted14 Jun 2015
Published08 Jul 2015


Background. Inflammation, together with related oxidative stress, is linked with the etiology of kwashiorkor, a form of severe acute malnutrition in children. A diet rich in anti-inflammatory and antioxidant phytochemicals may offer potential for the prevention and treatment of kwashiorkor. We selected and assayed five leafy green vegetables, two wild fruits, and six medicinal plants from Kenya for their antioxidant and anti-inflammatory properties. Consensus regarding medicinal plant use was established from ethnobotanical data. Methods. Antioxidant activity and phenolic content were determined using the oxygen radical absorbance capacity (ORAC) assay and Folin-Ciocalteu procedure, respectively. Anti-inflammatory activity was assessed in vitro targeting the inflammatory mediator tumour necrosis factor-alpha (TNF-α). Results. Mangifera indica (leaves used medicinally) showed the greatest antioxidant activity (5940 ± 632 µM TE/µg) and total phenolic content (337 ± 3 mg GAE/g) but Amaranthus dubius (leafy vegetable) showed the greatest inhibition of TNF-α (IC50 = 9 ± 1 μg/mL), followed by Ocimum americanum (medicinal plant) (IC50 = 16 ± 1 μg/mL). Informant consensus was significantly correlated with anti-inflammatory effects among active medicinal plants (). Conclusions. Several plant species commonly consumed by Kenyan children possess activity profiles relevant to the prevention and treatment of kwashiorkor and warrant further investigation.

1. Background

Kwashiorkor, a form of severe acute malnutrition in children, is a concern in Sub-Saharan Africa. Although the etiology of kwashiorkor remains misunderstood, proposed theories that implicate protein deficiency [1], aflatoxin contamination [2], and oxidative stress [3] inadequately explain the symptoms and biochemical evidence. Biochemical markers, as supported by a recent review, and differences in gut microbiome populations indicate that inflammation is likely a key component to the etiology of kwashiorkor [4, 5].

Children with kwashiorkor show elevated levels of inflammatory markers [6, 7], including TNF-α [6]. Moreover, fatty liver development, capillary membrane leak, and edema, all associated with kwashiorkor, can be potentiated by TNF-α [8, 9]. Bacterial overgrowth of the small intestine also has been documented in affected children [3], which can lead to increased TNF-α production in the liver [10]. The role of the gut microbiome in kwashiorkor was recently assessed by Smith et al. [5], who found that children with kwashiorkor had an overabundance of bacteria associated with inflammatory bowel disease and inducers of a proinflammatory T helper 1 response in their fecal microbiota. Therefore, a link between the gut microbiome and the inflammatory state seen in children with kwashiorkor appears likely.

As observed in many other diseases, inflammation and oxidative stress are mutually implicated in kwashiorkor. Antioxidant supplements have been previously used in treating and preventing kwashiorkor on the basis that oxidative stress was the primary underlying cause. However, the effectiveness of antioxidant supplements in treating or preventing kwashiorkor is debatable. Providing antioxidants to children with kwashiorkor through their diet improves survival [11, 12] but the use of antioxidant supplements does not appear to be effective as a preventative intervention [13]. Health benefits from antioxidants are more likely through synergistic interactions between nutrients taken in the diet, specifically the phytochemicals in vegetables and fruits [14], which are usually not included in antioxidant supplements. Whereas supplements are important for correcting nutritional deficiencies, long-term health benefits are more likely achieved through focusing on specific foods, nutrient interactions, and a diverse diet [15]. Additionally, if inflammation is the primary root cause, antioxidants would not address the underlying inflammatory condition. Therefore, the consumption of anti-inflammatory compounds and antioxidants through a diverse diet including whole foods may be more effective for prevention and treatment.

Leafy green vegetables (LGV) and fruits are important sources of polyphenols, which possess both anti-inflammatory and antioxidant properties [16, 17]. Moreover, wild-harvested plants, including LGV species indigenous to Sub-Saharan Africa, are often richer than exotic cultivars in terms of both polyphenol and nutrient content [18]. In Sub-Saharan countries, LGV represent vital components of the diet, notably for children during famine and drought, as many traditional cultivars and wild plant species are better adapted to local ecological conditions [19]. In addition, the use of plants for both food and medicine overlaps in many cultures in Sub-Saharan Africa [20], suggesting that medicinal plants already contribute to the diet of children.

With over 7100 documented plant species and more than 220 traditional LGV growing wild in Kenya [21] where kwashiorkor is an ongoing concern, this study sought to identify traditionally consumed LGV, wild fruits, and medicinal plants within a rural Kenyan context and characterize their antioxidant and anti-inflammatory properties. We selected materials for study based on dietary and medicinal data from interviews conducted with mothers in Makueni County, Eastern Kenya, on the plants most commonly eaten and/or used by their children. To the authors’ knowledge, no studies to date have assessed antioxidant and anti-inflammatory properties in plants based on their potential relevance for kwashiorkor.

2. Materials and Methods

2.1. Dietary Interviews

Plants for investigation were selected based on interviews of mothers who had at least one child under the age of five years. The mothers were randomly selected from household lists provided by the Assistant Chiefs from five different villages within Kaiti Division, Makueni County, Kenya. In total, 50 informed and consenting mothers, ten from each village, were interviewed from June to August 2011. Ethics approval was obtained from the Research Ethics Board of the Faculty of Agricultural and Environmental Sciences at McGill University, Montreal, Canada. The researcher had local approval through affiliation with the Kenya Agricultural Research Institute (KARI).

A Food Frequency Questionnaire (FFQ) was used to gather dietary information about the child’s intake of food items over the past seven days and throughout the different seasons (for vegetables and fruits only). The FFQ listed a total of 89 food items based on focus group data the researchers collected and a food item list developed by Bioversity International of wild foods from Kitui County, approximately 100 km from Makueni County. Twelve traditional LGV and twenty-five wild fruits were included in the FFQ.

2.2. Ethnobotanical Survey

Data about medicinal plants the mothers knew of or used for treating illnesses in children less than five years of age was gathered with a traditional knowledge/ethnobotanical survey that included a list of open-ended questions about malnutrition, kwashiorkor and its cause and treatment, plants used to treat malnutrition, and commonly used medicinal plants given to children. In addition, mothers were asked if they knew of plants used to treat eight specific illnesses or symptoms affecting children under five years (i.e., malaria, diarrhoea, pneumonia, swelling, flu/fever, skin diseases/rashes, inflammations, and additional GI tract symptoms).

These illnesses were queried due to the inflammatory cause of some and also to identify plants used for paediatric purposes which are likely to be safe, culturally appealing, and accessible. The participants were asked what part of the plant was used, what the preparation methods were, what the dose amount was, and how it was administered [22].

2.3. Consensus

A consensus analysis was modified from methodology developed by Leduc et al. [23]. Consensus takes into account (1) the number of different symptoms the plant is used to treat and (2) how frequently the plant is cited for any symptom by different correspondents, in this case the mothers [23]. The parameters for consensus are expressed in the following equation, modified from Leduc et al. [23]:

In the equation, is the symptom contribution for the plant, which is calculated for each symptom with if the symptom is not treated and if the symptom is treated by the plant. is the total number of mothers who provided ethnobotanical information (). is the total number of symptoms ( symptoms specifically asked about plus 22 additional symptoms mentioned = 30). is the citation frequency for the plant by all correspondents, which is calculated for each informant as if not cited and if cited to treat one or more symptoms. The sum of values would be the total citation frequency where the maximum total would be equal to [23].

2.4. Plant Collection and Processing

The most commonly consumed traditional LGV, wild fruits, and medicinal plants were collected, if available, through convenience sampling in Kaiti Division from July to August 2011. Five LGV, two wild fruits, and the leaves of six medicinal plants (Table 1) were harvested and identified by Patrick Maundu, a botanist at the National Museums of Kenya. Voucher specimens were deposited at the East African Herbarium in Nairobi and at McGill University.

Family namePlant species1Local name2Type of plantConsumption % during wet season3Total phenolics4
Mg GAE/g ± SEM  
( = 9–15)
ORAC activity5
M TE/g ± SEM  
( = 6–10)
Consensus value6

MeliaceaeAzadirachta indica A. Juss.MairobainiMedicinal778 ± 1E1761 ± 243CDEF0.0946
AmaranthaceaeAmaranthus dubius Mart. ex. Thell. MuchichaLGV90%39 ± 1G928 ± 43EF
BrassicaceaeBrassica oleracea L.SukumaLGV42%48 ± 2FG1184 ± 78DEF
CucurbitaceaeCucurbita maxima Duchesne. Matu ma malengeLGV65%24 ± 1H447 ± 71F0.0170
RosaceaeEriobotrya japonica (Thunb.) Lindl.NdundaWild fruit19%14 ± 2HI411 ± 15F
AnacardiaceaeMangifera indica L.MaembeMedicinal337 ± 3A5940 ± 632A0.0351
LamiaceaeOcimum americanum L. MutaaMedicinal136 ± 3C3190 ± 163BC0.1264
LamiaceaeOcimum gratissimum L.MukanduMedicinal86 ± 2DE1594 ± 168CDEF0.0591
MyrtaceaePsidium guajava L.MavelaMedicinal258 ± 1B3929 ± 411B0.0757
SolanaceaeSolanum scabrum Mill.KituluLGV55%92 ± 3D2675 ± 115BCD
FabaceaeVigna unguiculata (L.) Walp.Matu ma nthookoLGV73%54 ± 3F1233 ± 116DEF
VerbenaceaeVitex payos (Lour.) Merr.MuuWild fruit24%7 ± 1I179 ± 8F
RutaceaeZanthoxylum chalybeum Engl.MukeneaMedicinal92 ± 2D2414 ± 117CDE0.1598

Species and author names from The Plant List database. 2Name of plants in Kikamba language. 3The percentage represents the average of the two wet seasons. A FFQ was used to obtain the dietary data. 4Values for total phenolics were calculated as milligrams gallic acid equivalents (GAE) per gram dry extract. 5Values for ORAC were calculated as M Trolox equivalents (TE) per microgram dry extract. 6Consensus values for medicinal plant use by the mothers. 7All medicinal plants were used, collected, and analyzed as leaves. Superscripts represent statistical differences between plant species at using an ANOVA with Scheffé post hoc analysis.

Following collection all plant samples were washed with running water and air-dried and the fruits subsequently stored frozen (−6 to −18°C) and LGV and medicinal plants stored at 3 to 5°C until transfer to the University of Nairobi for freeze-drying within two weeks of collection. Freeze-dried plant samples were transferred to McGill University, Montreal, Canada, and stored in darkness at −20°C prior to extraction.

2.5. Plant Extractions

Freeze-dried LGV and medicinal plant leaves were ground using a Thomas Wiley Mini-Mill (Thomas Scientific) and a 20-mesh sieve. Flesh and peels of freeze-dried wild fruits were ground together using a mortar and pestle until the particles passed through the 20-mesh sieve. Ground plant samples were extracted using 80% ethanol according to the methodology described by Spoor et al. [24]. Nitrogen evaporation and freeze-drying were subsequently used to remove any remaining solvent with extracts stored in a desiccator at −20°C until experimental use.

2.6. Total Phenolics

To assess total phenolics, the Folin-Ciocalteu procedure was performed as described by Waterhouse [25]. Absorbance was read at 765 nm with a Synergy HT Multi-Mode Microplate Reader (Bio-Tek Instruments, Inc.). The mean blank value was subtracted from the standard and extract values. Total phenolic content was calculated based on a gallic acid standard curve and expressed as milligrams gallic acid equivalents (GAE) per gram of dry extract.

2.7. ORAC Assay

The ORAC assay was performed as previously described [26]. The change in fluorescence intensity over time was used to build the fluorescence decay curve compared to the decay curve of Trolox [27]. The final ORAC results were calculated as μM Trolox equivalents (TE) per μg of dry extract.

2.8. Cell Culture

All cell culture reagents were obtained from Wisent Inc. unless otherwise indicated. A human acute monocytic cell line (THP-1, ATCC) was cultured in Roswell Park Memorial Institute (RPMI) 1640 media supplemented with 10% fetal bovine serum, 0.05 mM beta-mercaptoethanol (Sigma-Aldrich Corp.), and 100 μg/mL penicillin and 100 μg/mL streptomycin in a 37°C humidified environment with 5% CO2. Cells were passed when they reached a cell density of approximately 8.0 × 105 cells/mL.

2.9. Cell Viability and Cytotoxicity

To ensure that plant extract concentrations were not toxic towards the THP-1 monocyte cells used in the TNF-α in vitro assay, a Vi-CELL Cell Viability Analyzer (Beckman Coulter Inc.) was used to determine cell viability using a trypan blue exclusion assay. Toxicity was tested to determine the highest nontoxic concentrations up to 100 μg/mL, the highest concentration tested in the TNF-α in vitro assay. If reduced cell viability was demonstrated (less than 80% viability), further tests were performed at 25, 50, and/or 75 μg/mL. Plant extracts, appropriately diluted in 80% EtOH, were added to THP-1 monocyte cells (3.0 × 105 cells/mL) in 12-well cell culture plates. A vehicle control, 80% EtOH, and a cell blank were also included in separate wells. The plate was then incubated at 37°C with 5% CO2 for 22 hours, which was equivalent to the total incubation period in the TNF-α in vitro assay.

Plant extracts that showed toxicity with the trypan blue assay were again solubilized in 80% EtOH and tested at 1, 10, 25, 30, 50, 75, and 100 μg/mL using a CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega Corp.), which is a sensitive measure of cytotoxicity. Plant extracts and 50 M H2O2 (positive control for maximal LDH release) or EtOH (vehicle control) were added to THP-1 monocyte cells (2.0 × 105 cells/mL) and incubated at 37°C with 5% CO2 for 22 hours. Following incubation, the plate was centrifuged at 2000 rpm for 10 minutes and then processed according to the manufacturer’s protocol. Absorbance was read at 490 nm with a Synergy HT Multi-Mode Microplate Reader (Bio-Tek Instruments, Inc.). Absorbance values were blanked against the media control and percent viability was subsequently determined compared to the positive control (H2O2) and vehicle control (EtOH). The LDH values standardized to the EtOH control were used for calculating the median toxic dose (TC50), the test concentration calculated to reduce cell viability by 50%.

2.10. TNF-α Release Assay

An in vitro model of anti-inflammatory activity involving the inhibition of TNF-α release in THP-1 cells stimulated by LPS was performed according to Black et al. [28] with minor modifications. A water control, 80% EtOH vehicle control, and positive control (parthenolide, 10 μg/mL and 1 μg/mL, Sigma-Aldrich Corp.) were used. The plant extracts were tested at 10 μg/mL and 50 μg/mL or 100 μg/mL (based on cytotoxicity data) for initial screening to identify active plants (THP-1 cell density of 1.01 × 105 cells/mL). All controls and extracts were assayed in quadruplicate. Plant extracts that reduced TNF-α release by at least 20% (relative to LPS-stimulated cells treated with vehicle) were subsequently tested at 1, 10, 25, 50, 75, and/or 100 μg/mL to characterize concentration-dependent effects and calculate IC50 values.

A Human TNF-α DuoSet ELISA kit (R&D Systems, Inc.) was used to quantify the amount of TNF-α released. The final TNF-α results were calculated as percent inhibition of TNF-α expression relative to the LPS-stimulated EtOH vehicle control and expressed as mean ± SEM ( = 11–32). To calculate the median inhibitory concentration (IC50) values, the means of the replicates for each concentration were plotted versus % inhibition (applying log transformations when warranted). The linear regression equation generated from the slope of the line was used to calculate the concentration at which inhibition was equal to 50% (i.e., IC50). The average of the three IC50 values was then taken to determine the overall IC50 value in μg/mL and expressed as mean ± SEM ( proportional groups of data for each test concentration).

2.11. Statistics

Statistical differences between plant extract activities in the ORAC and TNF-α assays were identified using an ANOVA with Scheffé post hoc analysis. Significant differences in TNF-α inhibition by plant extracts compared to the vehicle or positive control were identified using an ANOVA with posthoc Dunnett’s -test (alpha = 0.05). Pearson correlation analysis was used to determine the relationship between antioxidant capacity, anti-inflammatory activity, and total phenolics content. Correlation between consensus scores and laboratory results was assessed using the Pearson correlation test. SAS version 9.2 was used for all statistical procedures.

3. Results

3.1. Dietary and Medicinal Plant Use

Traditional LGV and wild fruits comprised around half the vegetable and fruit consumption of the children in the study for the previous seven days’ intake. The consumption of these LGV is likely higher during the wet seasons, as indicated by the percentage of children who consumed these plants (Table 1). Amaranthus dubius, Vigna unguiculata, Cucurbita maxima, and Solanum scabrum were among the most popular LGV for all participants (Table 1). C. maxima and S. scabrum were also cited in a medicinal context, such as treating malnutrition, stomach ache, or stomach ulcer. Wild fruit varieties were available in all seasons, which can be crucial during the dry season when fewer varieties of cultivated fruits are available.

Medicinal plants were used by 92% of the mothers to treat illnesses suffered by their children. Overall, participants reported using 97 medicinal plant preparations to treat 30 different symptoms; of these, 31 plants were used to treat the 8 specific symptoms targeted during interviews. Based on these results, 6 commonly used medicinal plants and one LGV used medicinally were collected. Consensus values were calculated for these seven plants, with Z. chalybeum and O. americanum showing the highest consensus (Table 1).

3.2. Total Phenolics and Antioxidant Activity

In general, medicinal plant extracts contained more phenolic metabolites and demonstrated stronger antioxidant activity than the LGV and wild fruits (Table 1). Three medicinal plants, M. indica, P. guajava, and O. americanum, had the highest phenolic content and greatest antioxidant activities, more than ten times the values obtained for wild fruit extracts. LGV extracts were richer in phenolic antioxidants than wild fruits but poorer than medicinal plants.The exception was S. scabrum, an LGV, which had the highest phenolic and ORAC scores among food plants (Table 1).

Total phenolic content and antioxidant activity among all plant extracts demonstrated a significant positive correlation (, , Pearson correlation analysis) but neither parameter correlated significantly with ethnobotanical consensus values.

3.3. Cell Viability

Six plants, A. dubius, A. indica, C. maxima, O. americanum, S. scabrum, and V. unguiculata, reduced cell viability by more than 20% at 100 μg/mL as indicated by both cell viability and cytotoxicity assays. After establishing concentration-dependent toxicity, we calculated the TC50 for these extracts and determined their highest nontoxic concentrations for use in the TNF-α assay (Table 2). The remaining seven extracts appeared nontoxic at 100 μg/mL, the maximum concentration subsequently administered to THP-1 cells.

Plant species
(g/mL ± SEM)
Highest test concentration (g/mL)2IC50
(g/mL ± SEM)3

Medicinal plants
 A. indica 204 ± 755058 ± 2C
 M. indica 100169 ± 6E
 O. americanum 80 ± 162516 ± 1AB
 O. gratissimum 100112 ± 6D
 P. guajava 100
 Z. chalybeum 10047 ± 1BC
Leafy green vegetables
 A. dubius 84 ± 3259 ± 1A
 B. oleracea 100111 ± 11D
 C. maxima 58 ± 3050131 ± 4D
 S. scabrum 114 ± 1650
 V. unguiculata 102 ± 95027 ± 5ABC
Wild fruits
 E. japonica 100
 V. payos 100

TC50 is the toxic dose, or the concentration calculated to reduce cell viability by 50%. = 4 replicates for each test concentration. 2Highest concentration tested that reduced cell viability by less than 20%. 3 = 3 proportional groups comprised of the results for each test concentration. Superscripts represent statistical differences between plant species at using an ANOVA with Scheffé post hoc analysis.

3.4. TNF-α Inhibition

Both medicinal plants and LGV were among the most effective inhibitors of LPS-induced TNF-α release in THP-1 cell cultures. A. dubius, an LGV, was the most potent extract, with a IC50 of 9 μg/mL, followed by O. americanum, V. unguiculata, and Z. chalybeum with IC50 values of 16, 27, and 47 μg/mL, respectively (Table 2 and Figure 1). B. oleracea, O. gratissimum, A. indica, and M. indica showed a weaker dose response yet nonetheless produced significant inhibition at their highest test concentrations (relative to LPS-stimulated cells treated with vehicle) (data not shown).

Neither fruit extract significantly affected observed TNF-α levels following LPS stimulation. Demonstrating a potential proinflammatory effect, S. scabrum, an LGV, significantly increased TNF-α expression at all test concentrations (10, 25, and 50 μg/mL; ; Figure 1).

We observed no correlation between inhibition of TNF-α release and phenolic content or antioxidant activity. However, a significant negative correlation (, ) was found between consensus and IC50 results for anti-inflammatory activity. The negative correlation indicates that as IC50 values decrease (i.e., anti-inflammatory activity increases), the consensus over plant use increases. The correlation was based on complete data for six plants with both consensus and IC50 values (Tables 1 and 2).

4. Discussion

Young children in rural Kenya are at high risk of developing kwashiorkor, a developmentally debilitating malnutrition condition associated with edema, oxidative stress, chronic inflammation, and fatty liver [3, 4]. Wild plants, whether used as food or medicine, not only provide nutritional benefits but also often contain antioxidant and anti-inflammatory phytochemicals that when incorporated into diet may help prevent or manage kwashiorkor. After interviewing mothers with at least one child under the age of five years, we identified seven food plants and six medicinal plants commonly consumed by children, with in vitro analyses subsequently revealing that the majority of extracts exhibited significant antioxidant and anti-inflammatory potential.

The medicinal plants, M. indica, P. guajava, and O. americanum, had the greatest total phenolic content and antioxidant activity, corroborating previous reports of potent antioxidant activity in the leaves of these plants [2931]. Several of the LGV demonstrated strong antioxidant and/or TNF-α inhibiting activity that was comparable to, or greater than, the activities of the medicinal plants. S. scabrum, one of the African nightshade species, was the LGV with the greatest total phenolic content and antioxidant activity. It is often used as an LGV and medicinal plant in Kenya and in other African countries [32]. Other studies corroborate the species’ potent antioxidant activity [33, 34].

A. dubius and V. unguiculata leaves are particularly important as they were the most commonly eaten LGV among interviewed mothers and children (Table 1). A. dubius, the most potent inhibitor of TNF-α release among the tested plants, not only is nutritionally rich [35] but also has shown antioxidant and anti-inflammatory activities in previous studies [36]. While the seeds of V. unguiculata similarly display anti-inflammatory and antioxidant activities [17, 37], this is the first report of potent anti-inflammatory activity in the leaves. Since these two species of LGV are also widely eaten across Kenya [21], the pertinence of our results may extend beyond the region of this study.

The flesh and peels of the two wild fruits, E. japonica and V. payos, showed relatively low levels of phenolic metabolites, antioxidant activity, and anti-inflammatory potential. Our results do not support a previous study reporting significant antioxidant activity in both the flesh and peels of V. payos [38]. The discrepancy may be due to differences in the variety or maturation stage of V. payos samples or in plant extraction protocols and antioxidant assays. The seeds of E. japonica have been tested more widely and show greater antioxidant and phenolic content than the flesh and peels [39]. However, both fruits likely contribute to the overall health of children due to their vitamin content, specifically vitamins C and beta-carotene [19, 40].

Medicinal plants are an important part of the local culture in Makueni County and were used for treating illnesses in children by 92% of the interviewed mothers. Also several plants, including O. americanum and P. guajava, were not only used when the child was sick but also given as a general digestion aid [41]. Additionally, Z. chalybeum is added to tea for flavour and can be taken to improve appetite or provide energy [41]. The use of the medicinal plants to treat childhood illness and plants given to children for health in general, moreover, may be important in the context of kwashiorkor if inflammation is involved in the etiology.

High consensus can identify plants that are well known and commonly used, which may be based on efficacy for treating illness; thus it would be expected to correlate with biological efficacy [42]. Of the identified medicinal plants, informant consensus was strongest for Z. chalybeum and O. americanum, species that demonstrated significant antioxidant and anti-inflammatory activity. Given the focus of inflammation among the symptoms targeted during interviews, moreover, the significant positive correlation between consensus values and anti-inflammatory activity suggests that mothers are selecting not only active medicinal species but also the more potent ones. With these analyses limited by the targeted nature of the interview questions and the number of species collected in this study, a more comprehensive assessment of ethnobotanical knowledge among Kenyan mothers is warranted.

The provision of identified species by mothers to children, together with low toxicity of extracts observed in cell culture, suggests that the plants are well tolerated, at least at low concentrations. However, several of these species (or related taxa) are known to contain toxic metabolites of potential concern, particularly when dealing with young children. S. scabrum, for example, is a member of the Solanum nigrum complex (black nightshades), which contains solanine and related toxic glycoalkaloids [43]. Unlike poisonous and often indistinguishable European nightshades [44], edible African nightshades are widely consumed for their nutritional and medicinal value, collected from the wild, and sold in markets [19]. Since the phylogeny and phytochemistry of Africa’s >30 wild Solanum species remain unclear, the leaves can be boiled or steamed prior to consumption, as this will remove the toxin [43].

Many Zanthoxylum species (Rutaceae) also contain toxic alkaloids [4548] that warrant caution. For Z. chalybeum, both ethnobotanical and experimental data indicate that the species in this study is relatively nontoxic [49]. A. indica was mildly cytotoxic in our study, as observed in brine shrimp [50]. Other identified species, such as Amaranthus spp. and C. maxima, have not demonstrated toxicity in previous studies [51]. Overall, while the studied medicinal plants, LGV, and fruits appear to pose limited risk to children, the potential for adverse effects persists, particularly with high doses or concomitant pharmacotherapies.

Additional epidemiological studies are needed to assess the potential for a diverse diet rich in vegetables and fruits with anti-inflammatory and antioxidant properties to improve health outcomes and reduce the risk of kwashiorkor development, with a consideration for potential toxicity. Local edible and medicinal plants, despite their accessibility and potential benefits, have yet to be studied in terms of either their specific impacts on kwashiorkor or their more broad contributions to child nutrition and health in rural Africa.

5. Conclusion

Beyond antioxidant activity, several of the studied medicinal plants and leafy green vegetables possess promising anti-inflammatory potential. Since mothers appear to select the more active plant species as food and medicine for their children, our results demonstrate both the cultural viability of these plants as potential foci for local food security and child health initiatives as well as the scientific and practical utility of linking biodiversity, ethnobotany, and pharmacology in search of viable and evidence-based interventions to address community health.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


The authors would like to acknowledge and thank the Kenyan mothers whose participation in this study contributed immeasurably to its success. This research was supported by a grant to T. Johns from the Canadian International Development Agency.


  1. C. D. Williams, “Kwashiorkor: a nutritional disease of children associated with a maize diet,” The Lancet, vol. 226, no. 5855, pp. 1151–1152, 1935. View at: Publisher Site | Google Scholar
  2. R. G. Hendrickse, “The influence of aflatoxins on child health in the tropics with particular reference to kwashiorkor,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 78, no. 4, pp. 427–435, 1984. View at: Publisher Site | Google Scholar
  3. M. H. N. Golden and D. Ramdath, “Free radicals in the pathogenesis of kwashiorkor,” Proceedings of the Nutrition Society, vol. 46, no. 1, pp. 53–68, 1987. View at: Publisher Site | Google Scholar
  4. S. N. Osorio, “Reconsidering kwashiorkor,” Topics in Clinical Nutrition, vol. 26, no. 1, pp. 10–13, 2011. View at: Publisher Site | Google Scholar
  5. M. I. Smith, T. Yatsunenko, M. J. Manary et al., “Gut microbiomes of Malawian twin pairs discordant for kwashiorkor,” Science, vol. 339, no. 6119, pp. 548–554, 2013. View at: Publisher Site | Google Scholar
  6. R. W. Sauerwein, J. A. Mulder, L. Mulder et al., “Inflammatory mediators in children with protein-energy malnutrition,” The American Journal of Clinical Nutrition, vol. 65, no. 5, pp. 1534–1539, 1997. View at: Google Scholar
  7. H. Dülger, M. Arik, M. R. Şekeroğlu et al., “Pro-inflammatory cytokines in Turkish children with protein-energy malnutrition,” Mediators of Inflammation, vol. 11, no. 6, pp. 363–365, 2002. View at: Publisher Site | Google Scholar
  8. M. F. Abdelmalek and A. M. Diehl, “Nonalcoholic fatty liver disease as a complication of insulin resistance,” Medical Clinics of North America, vol. 91, no. 6, pp. 1125–1149, 2007. View at: Publisher Site | Google Scholar
  9. M. P. Fuhrman, P. Charney, and C. M. Mueller, “Hepatic proteins and nutrition assessment,” Journal of the American Dietetic Association, vol. 104, no. 8, pp. 1258–1264, 2004. View at: Publisher Site | Google Scholar
  10. Z. Li, S. Yang, H. Lin et al., “Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease,” Hepatology, vol. 37, no. 2, pp. 343–350, 2003. View at: Publisher Site | Google Scholar
  11. K. Becker, J. Pons-Kühnemann, A. Fechner et al., “Effects of antioxidants on glutathione levels and clinical recovery from the malnutrition syndrome kwashiorkor—a pilot study,” Redox Report, vol. 10, no. 4, pp. 215–226, 2005. View at: Publisher Site | Google Scholar
  12. A. Badaloo, M. Reid, T. Forrester, W. C. Heird, and F. Jahoor, “Cysteine supplementation improves the erythrocyte glutathione synthesis rate in children with severe edematous malnutrition,” The American Journal of Clinical Nutrition, vol. 76, no. 3, pp. 646–652, 2002. View at: Google Scholar
  13. H. Ciliberto, M. Ciliberto, A. Briend, P. Ashorn, D. Bier, and M. Manary, “Antioxidant supplementation for the prevention of kwashiorkor in Malawian children: randomised, double blind, placebo controlled trial,” The British Medical Journal, vol. 330, no. 7500, pp. 1109–1111, 2005. View at: Publisher Site | Google Scholar
  14. R. H. Liu, “Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals,” The American Journal of Clinical Nutrition, vol. 78, no. 3, pp. 517S–520S, 2003. View at: Google Scholar
  15. D. R. Jacobs Jr., M. D. Gross, and L. C. Tapsell, “Food synergy: an operational concept for understanding nutrition,” The American Journal of Clinical Nutrition, vol. 89, no. 5, pp. 1543S–1548S, 2009. View at: Publisher Site | Google Scholar
  16. A. Scalbert, I. T. Johnson, and M. Saltmarsh, “Polyphenols: antioxidants and beyond,” The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 215S–217S, 2005. View at: Google Scholar
  17. R. Gautam and S. M. Jachak, “Recent developments in anti-inflammatory natural products,” Medicinal Research Reviews, vol. 29, no. 5, pp. 767–820, 2009. View at: Publisher Site | Google Scholar
  18. N. P. Uusiku, A. Oelofse, K. G. Duodu, M. J. Bester, and M. Faber, “Nutritional value of leafy vegetables of sub-Saharan Africa and their potential contribution to human health: a review,” Journal of Food Composition and Analysis, vol. 23, no. 6, pp. 499–509, 2010. View at: Publisher Site | Google Scholar
  19. P. M. Maundu, G. W. Ngugi, and C. H. S. Kabuye, Traditional Foods Plants of Kenya, National Museums of Kenya, Nairobi, Kenya, 1999.
  20. N. L. Etkin, Ed., Plants in Indigenous Medicine and Diet: Biobehaviour Approaches, Redgrave Publishing Company, Bedford Hills, NY, USA, 1986.
  21. P. M. Maundu, E. I. Njiro, J. A. Chweya, J. K. Imungi, and E. N. Seme, “Kenya,” in The Biodiversity of Traditional Leafy Vegetables, J. A. Chweya and P. B. Eyzaguirre, Eds., International Plant Genetic Resources Institute, Rome, Italy, 1999. View at: Google Scholar
  22. I. Norscia and S. M. Borgognini-Tarli, “Ethnobotanical reputation of plant species from two forests of Madagascar: a preliminary investigation,” South African Journal of Botany, vol. 72, no. 4, pp. 656–660, 2006. View at: Publisher Site | Google Scholar
  23. C. Leduc, J. Coonishish, P. Haddad, and A. Cuerrier, “Plants used by the Cree Nation of Eeyou Istchee (Quebec, Canada) for the treatment of diabetes: a novel approach in quantitative ethnobotany,” Journal of Ethnopharmacology, vol. 105, no. 1-2, pp. 55–63, 2006. View at: Publisher Site | Google Scholar
  24. D. C. A. Spoor, L. C. Martineau, C. Leduc et al., “Selected plant species from the Cree pharmacopoeia of northern Quebec possess anti-diabetic potential,” Canadian Journal of Physiology and Pharmacology, vol. 84, no. 8-9, pp. 847–858, 2006. View at: Publisher Site | Google Scholar
  25. A. L. Waterhouse, “Determination of total phenolics,” in Current Protocols in Food Analytical Chemistry, John Wiley & Sons, 2001. View at: Google Scholar
  26. C. S. Harris, L.-P. Beaulieu, M.-H. Fraser et al., “Inhibition of advanced glycation end product formation by medicinal plant extracts correlates with phenolic metabolites and antioxidant activity,” Planta Medica, vol. 77, no. 2, pp. 196–204, 2011. View at: Publisher Site | Google Scholar
  27. K. M. Gillespie, J. M. Chae, and E. A. Ainsworth, “Rapid measurement of total antioxidant capacity in plants,” Nature Protocols, vol. 2, no. 4, pp. 867–870, 2007. View at: Publisher Site | Google Scholar
  28. P. Black, A. Saleem, A. Dunford et al., “Seasonal variation of phenolic constituents and medicinal activities of northern labrador tea, Rhododendron tomentosum ssp. subarcticum, an Inuit and cree first nations traditional medicine,” Planta Medica, vol. 77, no. 14, pp. 1655–1662, 2011. View at: Publisher Site | Google Scholar
  29. L. T. Ling, S.-A. Yap, A. K. Radhakrishnan, T. Subramaniam, H. M. Cheng, and U. D. Palanisamy, “Standardised Mangifera indica extract is an ideal antioxidant,” Food Chemistry, vol. 113, no. 4, pp. 1154–1159, 2009. View at: Publisher Site | Google Scholar
  30. H.-Y. Chen and G.-C. Yen, “Antioxidant activity and free radical-scavenging capacity of extracts from guava (Psidium guajava L.) leaves,” Food Chemistry, vol. 101, no. 2, pp. 686–694, 2007. View at: Publisher Site | Google Scholar
  31. F. L. Hakkim, G. Arivazhagan, and R. Boopathy, “Antioxidant property of selected Ocimum species and their secondary metabolite content,” Journal of Medicinal Plants Research, vol. 2, pp. 250–257, 2008. View at: Google Scholar
  32. G. N. Mwai, J. C. Onyango, and M. O. Abukusta-Onyango, “Taxonomic identification and characterization of African nightshade (Solanum L. Section Solanum),” African Journal of Food, Agriculture, Nutrition and Development, vol. 7, no. 4, 2007. View at: Google Scholar
  33. E. K. Mibei, N. K. Ojijo, S. M. Karanja, and J. K. Kinyua, “Phytochemical and antioxidant analysis of methanolic extracts of four African indigenous leafy vegetables,” Annals Food Science and Technology, vol. 13, pp. 37–42, 2012. View at: Google Scholar
  34. C. Anokwuru, G. Anyasor, O. Ajibaye, O. Fakoya, and P. Okebugwu, “Effect of extraction solvents on phenolic, flavonoid and antioxidant activities of three Nigerian medicinal plants,” Nature and Science, vol. 9, no. 7, pp. 53–61, 2011. View at: Google Scholar
  35. B. Odhav, S. Beekrum, U. Akula, and H. Baijnath, “Preliminary assessment of nutritional value of traditional leafy vegetables in KwaZulu-Natal, South Africa,” Journal of Food Composition and Analysis, vol. 20, no. 5, pp. 430–435, 2007. View at: Publisher Site | Google Scholar
  36. U. S. Akula and B. Odhav, “In vitro 5-lipoxygenase inhibition of polyphenolic antioxidants from undomesticated plants of South Africa,” Journal of Medicinal Plants Research, vol. 2, pp. 207–212, 2008. View at: Google Scholar
  37. P. Siddhuraju and K. Becker, “The antioxidant and free radical scavenging activities of processed cowpea (Vigna unguiculata (L.) Walp.) seed extracts,” Food Chemistry, vol. 101, no. 1, pp. 10–19, 2006. View at: Publisher Site | Google Scholar
  38. A. R. Ndhlala, C. H. Mupure, K. Chitindingu, M. A. N. Benhura, and M. Muchuweti, “Antioxidant potentials and degress of polymerization of six wild fruits,” in Antioxidant Potentials and Degress of Polymerization of Six Wild Fruits, vol. 1, pp. 87–92, Scientific and Research Essay, 2006. View at: Google Scholar
  39. K. Koba, A. Matsuoka, K. Osada, and Y.-S. Huang, “Effect of loquat (Eriobotrya japonica) extracts on LDL oxidation,” Food Chemistry, vol. 104, no. 1, pp. 308–316, 2007. View at: Publisher Site | Google Scholar
  40. A. Nyambo, A. Nyomora, C. K. Ruffo, and B. Tengnas, Fruits and Nuts: Species with Potential for Tanzania, Regional Land Management Unit (RELMA in ICRAF), World Agroforestry Centre, Nairobi, Kenya, 2005.
  41. H. R. Tufts, The Anti-Inflammatory and Antioxidant Properties of Kenyan Leafy Green Vegetables, Wild Fruits, and Medicinal Plants: Relation of the Health-Promoting Properties of Biodiversity to Contribute to Kwashiorkor Alleviation, School of Dietetics and Human Nutrition, McGill University, 2012.
  42. D. E. Moerman, “Agreement and meaning: rethinking consensus analysis,” Journal of Ethnopharmacology, vol. 112, no. 3, pp. 451–460, 2007. View at: Publisher Site | Google Scholar
  43. M. S. Defelice, “The black nightshades, Solanum nigrum L. et al.: poison, poultice, and pie,” Weed Technology, vol. 17, no. 2, pp. 421–427, 2003. View at: Publisher Site | Google Scholar
  44. E. A. Olet, M. Heun, and K. A. Lye, “African crop or poisonous nightshade; the enigma of poisonous or edible black nightshade solved,” African Journal of Ecology, vol. 43, no. 2, pp. 158–161, 2005. View at: Publisher Site | Google Scholar
  45. A. Kato, M. Moriyasu, M. Ichimaru et al., “Isolation of alkaloidal constituents of Zanthoxylum usambarense and Zanthoxylum chalybeum using ion-pair HPLC,” Journal of Natural Products, vol. 59, no. 3, pp. 316–318, 1996. View at: Publisher Site | Google Scholar
  46. M. F. Musila, S. F. Dossaji, J. M. Nguta, C. W. Lukhoba, and J. M. Munyao, “In vivo antimalarial activity, toxicity and phytochemical screening of selected antimalarial plants,” Journal of Ethnopharmacology, vol. 146, no. 2, pp. 557–561, 2013. View at: Publisher Site | Google Scholar
  47. A. Kamuhabwa, C. Nshimo, and P. de Witte, “Cytotoxicity of some medicinal plant extracts used in Tanzanian traditional medicine,” Journal of Ethnopharmacology, vol. 70, no. 2, pp. 143–149, 2000. View at: Publisher Site | Google Scholar
  48. R. Muganga, L. Angenot, M. Tits, and M. Frédérich, “In vitro and in vivo antiplasmodial activity of three rwandan medicinal plants and identification of their active compounds,” Planta Medica, vol. 80, no. 6, pp. 482–489, 2014. View at: Publisher Site | Google Scholar
  49. P. E. Ogwang, R. Tumusiime, M. Agwaya et al., “Repeat-dose effects of Zanthoxylum chalybeum root bark extract: a traditional medicinal plant used for various diseases in Uganda,” African Journal of Pharmacy and Pharmacology, vol. 2, pp. 101–105, 2003. View at: Google Scholar
  50. G. G. Mwangi, J. M. Wagacha, J. M. Nguta, and J. M. Mbaria, “Brine shrimp cytotoxicity and antimalarial activity of plants traditionally used in treatment of malaria in Msambweni district,” Pharmaceutical Biology, vol. 53, no. 4, pp. 588–593, 2015. View at: Publisher Site | Google Scholar
  51. F. Orech, T. Akenga, J. Ochora, H. Friis, and J. Aagaard-Hansen, “Potential toxicity of some traditional leafy vegetables consumed in Nyang'oma Division, Western Kenya,” African Journal of Food, Agriculture, Nutrition and Development, vol. 5, pp. 1–13, 2005. View at: Google Scholar

Copyright © 2015 H. R. Tufts et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.